Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Ependymoma × Etoposide × Clear all

Phase

Phase 2 7 Phase 1 3 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 18 Lymphoma, Large B-Cell, Diffuse 16 Leukemia, Myeloid, Acute 16 Hodgkin Disease 16 Lymphoma 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Lymphoma, Non-Hodgkin 12 Lung Neoplasms 12 Lymphoma, Mantle-Cell 10 Lymphoma, Follicular 10 Leukemia 10 Lymphoma, B-Cell 7 Carcinoma, Non-Small-Cell Lung 7 Burkitt Lymphoma 6 Recurrence 5 Lymphoma, Large-Cell, Immunoblastic 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Lymphoma, T-Cell 4 Lymphoma, Large-Cell, Anaplastic 4 Lymphoma, B-Cell, Marginal Zone 4 Congenital Abnormalities 4 Waldenstrom Macroglobulinemia 3 Plasmablastic Lymphoma 3 Ovarian Neoplasms 3 Lymphoma, Primary Effusion 3 Leukemia, Myelomonocytic, Acute 3 Leukemia, Monocytic, Acute 3 Leukemia, Megakaryoblastic, Acute 3 Leukemia, Erythroblastic, Acute 3 Immunoblastic Lymphadenopathy 3

Interventions

Temozolomide 3 Nivolumab 2 veliparib 1 picropodophyllin 1 lutetium Lu 177 dotatate 1 dostarlimab 1 dinutuximab 1 bempegaldesleukin 1 abemaciclib 1 Radiotherapy 1 Proton Therapy 1 Irinotecan 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Etoposide 1 Ethanol 1 Carmustine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06485908 2024-07-03

MEPENDAX

Assistance Publique Hopitaux De Marseille

Phase 1/2 Not yet recruiting

Ependymoma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡